Metraipolis › archive › dc_7c68ebb49bb4

Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancer — Europe PMC PMID:41323499

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41323499
DOI
10.3389/pore.2025.1612266
License (as archived)
solo-consultazione
Archived
2026-11-08T14:37:37.574Z
SHA-256 of the archived text
1e34f4973b47d377c19950882fb0497238fecf507378ddfa406f13685aa5e017
Stable URL of this page
https://metraipolis.com/documento/dc_7c68ebb49bb4

How to cite

Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancer — Europe PMC PMID:41323499 — Europe PMC (en), https://europepmc.org/article/MED/41323499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c68ebb49bb4 (Metraipolis archive dc_7c68ebb49bb4, sha256 1e34f4973b47d377c19950882fb0497238fecf507378ddfa406f13685aa5e017)
BibTeX
@misc{dc7c68ebb49bb4,
  title = {Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancer — Europe PMC PMID:41323499},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41323499},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c68ebb49bb4; sha256 1e34f4973b47d377c19950882fb0497238fecf507378ddfa406f13685aa5e017},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41323499. Agents can read the archived copy with the MCP tool read_document.